VelaShape III provides a highly effective solution for comfortable, non-invasive, body contouring by treating cellulite and delivering circumference reduction with visible results in as little as one treatment1.
With more than 1 million VelaShape procedures performed each year, VelaShape III has proven time and time again its ability to deliver noticeable, measureable and consistent results. Treating cellulite, skin tightening and body contouring, VelaShape provides long-lasting results with little to no downtime or significant discomfort.
Powered by Syneron Candela’s patented elōs technology, VelaShape is the first and only device to combine IR (infrared), bipolar RF (radiofrequency) and vacuum to precisely and effectively heat the tissue up to 3mm and 15mm depth respectively. This type of efficient heating and vacuum stimulates the growth of new and better collagen and elastin, which results in a localised reduction in skin laxity, body volume and an overall improvement in skin structure and texture.
VelaShape III boasts the better-than-ever new Guided Mode, offering an enhanced treatment experience for both patients and operators. The advanced software simplifies operation and minimises technique sensitivity, further improving comfort level. The result: even more reliable and effective treatments, every time.
Demonstrating it’s efficacy, in a clinical study patients experienced an average of 29% reduction of fat layer thickness and 97% patient satisfaction*2. VelaShape achieves an average circumference reduction of 1-3cm post treatment2,3,4, helping to change patients’ lives, improve self esteem and ease self-image issues.
By 2019 more than 10 million body shaping and skin tightening procedures are expected to be performed, making it the fastest growing market segment5. VelaShape III is the affordable answer to tap into this growing market, with its superior efficacy, shorter treatment times and ease-of-use helping to drive revenue and grow a successful business.
To find out more, click here.
Syneron Candela
Unit 14 / 8 Campbell Street, Artarmon Sydney 2064 Australia
1300 (CANDELA) 226 335
www.syneron-candela.com
info.au@syneron-candela.com
*Between baseline and the 1-month follow up
References: 1. Ruthie Amir, MD, Clinical evaluation on the efficacy and safety of the Velashape III device for abdominal circumferential reduction treatment, Syneron Candela, data on file. 2. Maurice A. Adatto, Robyn M. Adatto-Neilson, Grietje Morren. Reduction in adipose tissue volume using a new high-power radiofrequency technology combined with infrared light and mechanical manipulation for body contouring. Lasers Med Sci 2013; 1-5. 3. Source: Syneron proprietary consumer survey 2012 and 2015 4. Maurice A. Adatto, Robyn M. Adatto-Neilson, Grietje Morren. Reduction in adipose tissue volume using a new high-power radiofrequency technology combined with infrared light and mechanical manipulation for body contouring. Lasers Med Sci 2013; 1-5. 5. Professional, non-invasive, energy-based. Source: Medical Insight Inc., 2015